ECMO: Optimization of Its Use

Terminated

• Conditions: Extracorporeal Membrane Oxygenation Complication

• Registration Number: NCT02280460
• Lead Sponsor: Renzo Loyaga Rendon

Brief Summary

To create a local registry for ECMO patients.

Detailed Description

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Study Timeline

• Study Start: 2014-09
• Study First Submitted: 2014-10-29
• Study First Submitted QC: 2014-10-29
• Study First Posted: 2014-10-31
• Primary Completion: 2024-05-29
• Study Completion: 2024-05-29
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-03
• Last Update Posted: 2024-06-05

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 921

Inclusion Criteria

• Age >18
• requiring ECMO. For the control,Patients without ECMO admited to ICU.

Exclusion Criteria

• Age<18
• Known prisoner of the state

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All cause mortality	1 year

Secondary Outcome Measures

Name	Time	Method
all cause mortality	48 hours
In-house mortality	30 day

Trial Locations

Locations (1)

Spectrum Health; 🇺🇸 Grand Rapids, Michigan, United States